Episode 25025
The Science of a Stronger Heart... Robert Blum, CEO, CytoKinetics
BioTech Nation ... with Dr. Moira Gunn · Moira Gunn
July 2, 202515m 47s
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This week on BioTech Nation, Robert Blum, CEO of CytoKinetics, joins me to talk about the company’s decades-long mission to keep hearts beating stronger and longer. With one heart drug under FDA review and more in the pipeline, CytoKinetics is working to address the full spectrum of heart failure, from weak hearts to overactive ones, and even exploring muscle health beyond the heart to support healthy aging.
Topics
heart failurecardiac healthhypertrophic cardiomyopathyFDA approvalCytokineticsRobert Blummuscle activatorcardiac inhibitorclinical trialsheart diseasebiotech innovationskeletal musclehealthy agingdrug developmentcardiologyheart functiongene-linked conditionspatient caremuscle biologyBioTech Nation